AdaptHealth director receives stock awards

SAMET KENNETH A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

SAMET KENNETH A reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. director Kenneth A. Samet reported two stock awards of common shares. On June 24, he received 6,070 shares at a reference price of $9.89 per share, bringing that holding line to 25,069 shares. He also received 18,999 restricted stock units at no cost, which will be settled in common stock upon vesting, with 18,999 shares shown as held after that award. These are compensation-related grants, not market purchases or sales.

Insider Trade Summary

Grant/Award: 25,069 shares

Grant/Award 2 txns

Insider SAMET KENNETH A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00
Grant/Award	Common Stock	6,070	$9.89	$60K

Holdings After Transaction: Common Stock — 25,069 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

Stock award 1: 6,070 shares Award 1 reference price: $9.89 per share Shares after award 1: 25,069 shares +3 more

6 metrics

Stock award 1 6,070 shares Common Stock grant on June 24, price $9.89

Award 1 reference price $9.89 per share Common Stock grant on June 24

Shares after award 1 25,069 shares Total shares following first transaction line

Restricted stock units grant 18,999 units RSUs to be settled in common stock upon vesting

RSU grant price $0.00 per unit Compensation grant with no cash cost at grant

Shares after RSU line 18,999 shares Total shares following RSU transaction line

Key Terms

Common Stock, restricted stock units, total shares following transaction, grant, award, or other acquisition

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

restricted stock units financial

"These shares represent restricted stock units and will be settled"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

total shares following transaction financial

"total_shares_following_transaction": "25069.0000""

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AdaptHealth (AHCO) director Kenneth A. Samet report in this Form 4?

Kenneth A. Samet reported receiving two stock awards of AdaptHealth common stock. One grant was 6,070 shares and another was 18,999 restricted stock units, both recorded on June 24 as compensation-related acquisitions, not open-market purchases or sales.

How many AdaptHealth shares did Kenneth A. Samet receive in each grant?

Samet received 6,070 shares of AdaptHealth common stock in one award and 18,999 restricted stock units in a separate award. Each grant is reported separately, with its own post-transaction holding balance noted in the filing data.

What prices are associated with Kenneth A. Samet’s AdaptHealth stock awards?

The 6,070-share award references a price of $9.89 per share, while the 18,999 restricted stock units show a price of $0.00, indicating no cash cost to Samet. These are compensation grants, not purchases in the open market.

What are the post-transaction holdings shown for Kenneth A. Samet in AdaptHealth stock?

For the first line, the filing lists 25,069 AdaptHealth common shares following the 6,070-share award. For the restricted stock unit grant, it lists 18,999 shares following that award. Each figure reflects holdings tied to the respective reported transaction line.

How are the 18,999 AdaptHealth restricted stock units for Kenneth A. Samet settled?

The 18,999 units are restricted stock units that will be settled in AdaptHealth common stock upon vesting. According to the footnote, they convert into common shares when vesting conditions are met, rather than requiring any cash payment at grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SAMET KENNETH A

(Last) (First) (Middle)

C/O ADAPTHEALTH CORP.

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999(1)	A	$0	18,999	D
Common Stock	06/24/2026		A		6,070(1)	A	$9.89	25,069	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 26, 2026 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Kenneth A. Samet	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)